University of Turku
Turku, 20014, Finland
Location status: Recruiting
NCT Number: NCT07310472
The goal of this intervention study is to learn if giving children influenza vaccinations in early childhood education facilities (i.e., daycare) will increase vaccination coverage compared to giving vaccinations only at healthcare. The main question it aims to answer is:
• Does offering children nasal influenza vaccine in daycare result in higher proportion of children getting influenza vaccine.
Researchers will compare daycare setting and healthcare setting as the location of giving influenza vaccines to children to see if more children will get vaccinated if they have an opportunity to receive nasal influenza vaccine at daycare.
Participants in the intervention group will:
• Have the opportunity to receive influenza vaccine in the daycare or in the healthcare
Participants in the comparison group will:
• Have the opportunity to receive influenza vaccine in the healthcare only
Interested in participating?
Request Info2 year–6 year
All sexes
Interventional
Not applicable
Turku, 20014, Finland
Location status: Recruiting
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention is the possibility to get influenza vaccine in the daycare, in comparison to routine practice of getting influenza vaccine in a healthcare setting.
Time frame: From enrollment to the end of seasonal influenza vaccinations about 3 to 10 weeks later.
Study child receiving any influenza vaccine
Contact information is provided by the study sponsor or research team.
Turku University Hospital
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04367883
ACE Inhibitors, ARB
Terrassa, Barcelona, Spain
View Trial DetailsNCT03346772
Infections, Influenza Vaccination
Philadelphia, Pennsylvania, United States
View Trial DetailsNCT07164144
Infections, Influenza Vaccination
Rochester, New York, United States
View Trial DetailsNCT06850051
Healthy Volunteers, Human Metapneumovirus Vaccination
Blacktown, New South Wales, Australia
View Trial Details